Evidence map›Paper›PMID 34820927›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2022

Objective validity of patient-reported symptoms in aspirin-exacerbated respiratory disease patients.

Pooja P Patel, Jing Cui, Katherine N Cahill, Tanya M Laidlaw

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pooja P PatelDepartment of Medicine, Beth Israel Deaconess Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-9443-2220
Jing CuiDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0001-8657-1741
Katherine N CahillDepartment of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Tanya M LaidlawDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0001-6709-9795

Funding

Prostaglandin D2: A Key Mediator of Aspirin-Exacerbated Respiratory DiseaseR01HL128241 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LAIDLAW, TANYA MARIA · 2015 to 2019
$2.2M
The Role of IL-5 and Local Nasal Polyp Immunoglobulin Production in Aspirin-Exacerbated Respiratory DiseaseK23AI139352 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BUCHHEIT, KATHLEEN MARY · 2019 to 2023
$1.0M
THE ROLE OF PROSTAGLANDIN D2 IN THE RESPIRATORY SYMPTOMS OF ASPIRIN EXACERBATED RESPIRATORY DISEASEK23AI118804 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CAHILL, KATHERINE N · 2015 to 2019
$951k
Division of Intramural Research, National Institute of Allergy and Infectious DiseasesNHLBI NIH HHS R01 HL128241NIAID NIH HHS K23 AI118804NIAID NIH HHS K23 AI139352
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Asthma, Aspirin-InducedAnti-Inflammatory Agents, Non-SteroidalAspirinHumansPatient Reported Outcome MeasuresAnti-Inflammatory Agents, Non-SteroidalAspirin

Identifiers

PMID34820927
PMCPMC8810664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.